Session Type
Meeting
Search Results for hepatitis
Abstract Number: 828
Hospital Medicine 2020, Virtual Competition
Case Presentation: A 21-year-old healthy Hispanic male presented to the hospital for evaluation of fever and sore throat for 4 weeks. He had no significant past medical history and he was not on any medications. His vital signs were within normal limits. Physical exam revealed icterus and no hepatosplenomegaly. The remainder of the physical exam […]
Abstract Number: 836
SHM Converge 2024
Case Presentation: An 84 year old female with a past medical history of stroke, hypertension, hyperlipidemia, hypothyroidism, cataracts, glaucoma and recent diagnosis of autoimmune hepatitis presented with shortness of breath and abdominal pain. Three months prior to admission, the patient had been admitted and found to have acute liver failure secondary to autoimmune hepatitis and […]
Abstract Number: 837
SHM Converge 2024
Case Presentation: A 33-year-old man with recent travel to India presented with fevers, abdominal pain, and bloody stools. He was admitted two weeks prior to a hospital in India for fever and right upper quadrant pain where he was found to have elevated liver enzymes (ALT 569, AST 390, total bilirubin 9.9) in addition to […]
Abstract Number: 845
Hospital Medicine 2019, March 24-27, National Harbor, Md.
Case Presentation: A 20 year old female with two prior typhoid episodes, presented to the hospital with a three week history of epigastric pain. The patient returned from a one month trip to Bangladesh four weeks prior. She subsequently began experiencing squeezing epigastric pain, subjective fevers, yellow discoloration of her skin, and decreased oral intake. […]
Abstract Number: 852
SHM Converge 2023
Case Presentation: Hepatitis B is a viral infection that attacks the liver and can cause both acute and chronic disease. The WHO estimates 1.5 million new infections each year. Most people remain asymptomatic. However, some people have acute illness that lasts several weeks, which can be complicated by acute liver failure. Glucose-6-phosphate dehydrogenase (G6PD) deficiency […]
Abstract Number: 927
Hospital Medicine 2020, Virtual Competition
Case Presentation: A 64-year-old man with diet-controlled type 2 diabetes mellitus and hyperlipidemia presented to an academic center with painless jaundice. He was in his usual state of health until 2 weeks prior to presentation when he noticed dark urine. He then developed jaundice 4 days before his presentation. Initial laboratory testing was notable for […]
Abstract Number: 958
Hospital Medicine 2020, Virtual Competition
Case Presentation: A 55-year-old male with a history of hypertension and bipolar disorder presented with abdominal and groin pain, and unintentional 40lb weight loss over the past 4 months. Furthermore he reported fevers, chills, hematuria, and dysuria. On physical exam he had right upper quadrant abdominal tenderness, bilateral hard and immobile inguinal lymph nodes, and […]
Abstract Number: I26
SHM Converge 2022
Case Presentation: A 77-year-old female was admitted with a 3-week history of pruritus and a 1-week history of jaundice and fatigue. Patient had not used any new medications, except for recently prescribed ACE inhibitors. There was no history of alcohol abuse or liver disease and no recent sick contacts. Other medical conditions are type 2 […]
Abstract Number: L42
SHM Converge 2022
Case Presentation: A 19-year-old female presented with 1 month of worsening abdominal pain, 3 weeks of fevers / chills, 1 week of nausea/vomiting, and 4 days of rash. Her abdominal pain was intermittent, stabbing, diffuse, and worsening in severity. She also had daily chills and fevers (maximum temperature of 38.9 °C). Her emesis was non-bilious […]
Abstract Number: L46
SHM Converge 2022
Case Presentation: Immune checkpoint inhibitors have evolved into the conventional therapy regimen for many cancer types. The major categories of immune checkpoint inhibitors include monoclonal antibodies against cytotoxic T lymphocyte antigen (CTLA-4), programmed cell death protein-1 (PD-1) and programmed cell death ligand molecules (PD-L1). Pembrolizumab has been implicated in causing hepatitis Discussion: An 89-year-old Caucasian […]